/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

GlucoTrack Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$5.79 -0.0203(-2.03%) GCTK at 04 Dec 2025 04:33 PM Medical Instruments & Supplies
Lowest Today 5.99
Highest Today 6.1182
Today’s Open 6.09
Prev. Close 5.91
52 Week High 468.00
52 Week Low 4.22
Day’s Range: Low 5.99 High 6.1182
52-Week Range: Low 4.22 High 468.00
1 day return -
1 Week return -11.48
1 month return -1.95
3 month return +26.26
6 month return +4108.68
1 year return +2090.23
3 year return -
5 year return -
10 year return -

Institutional Holdings

Bank of America Corp 0.45

Fidelity Extended Market Index 0.22

Tower Research Capital LLC 0.20

Barclays PLC 0.08

Spartan Total Market Index Pool G 0.01

Victory Extended Market Index 0.01

Newbridge Financial Services Group, Inc. 0.00

FMR Inc 0.00

SBI Securities Co Ltd 0.00

Fidelity Series Total Market Index 0.00

Advisor Group Holdings, Inc. 0.00

Morgan Stanley - Brokerage Accounts 0.00

Northwestern Mutual Wealth Management Co 0.00

UBS Group AG 0.00

HRT FINANCIAL LLC 0.00

Virtu Financial LLC 0.00

XTX Topco Ltd 0.00

Market Status

Fundamentals

Market Cap 5.36 M

PB Ratio 2.2511

PE Ratio 0.0

Enterprise Value 1.62 M

Total Assets 5.93 M

Volume 20663

Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:208762 0.2M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:208762 0.2M

Annual Net worth FY23:-5972000 -6.0M, FY22:-4438000 -4.4M, FY21:-4100000 -4.1M, FY20:-2598000 -2.6M, FY19:-3516189 -3.5M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-9000 -0.0M, Q2/2025:-11000 -0.0M, Q1/2025:-8000 -0.0M, Q3/2024:null 0.0M, Q2/2024:-8000 -0.0M

Quarterly Net worth Q3/2025:-4171000 -4.2M, Q2/2025:-4756000 -4.8M, Q1/2025:-6833000 -6.8M, Q3/2024:-5087000 -5.1M, Q2/2024:-4489000 -4.5M

Fund house & investment objective

Company Information GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack, a non-invasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain through a small sensor clipped onto the earlobe. It is also developing the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Organisation Medical Instruments & Supplies

Employees 11

Industry Medical Instruments & Supplies

CEO Dr. Paul V. Goode Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow